Please assess the completion status of the following clinical trial:

Trial Title: Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* Positive blood culture during the study period.~* No positive blood cultures in prior 7 days~* Minnesota state research authorization provided~Exclusion criteria:~* No Minnesota state research authorization~* Deceased or transitioned to comfort care within 24 hours of enrollment~* Positive blood culture in prior 7 days~* Previously enrolled in this study~* Negative Gram stain

- Gender: ALL
- Minimum Age: None
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: EXPERIMENTAL): Standard Mayo practices (bacterial culture and susceptibility testing) will be used. FilmArray testing will not be performed.
- FilmArray test (Type: EXPERIMENTAL): Standard Mayo practices will be used AND FilmArray testing will be performed. Results of the FilmArray Blood Culture ID Panel test will be communicated to the service by phone in real-time, 24 hours a day, 7 days a week.
- FilmArray plus antimicrobial stewardship (Type: EXPERIMENTAL): Standard Mayo practices will be used. FilmArray testing will be performed and reported as above, for intervention group 1. IN ADDITION, an expert will review the subject's FilmArray Blood Culture ID Panel result and medical record and contact the primary service if a modification of antimicrobial therapy may be appropriate.

Based on this trial design, predict the completion outcome and termination type (if applicable).